Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIALYTE LM DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIALYTE LM DEXTROSE 1 5 IN PLASTIC CONTAINER.
DELFLEX-LM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Delflex-LM with Dextrose 2.5% is a peritoneal dialysis solution. Dextrose provides osmotic gradient for ultrafiltration; lactate (LM) is a bicarbonate precursor that buffers metabolic acidosis. The solution replaces fluid and electrolytes while removing waste products via diffusion and convection across the peritoneal membrane.
Peritoneal dialysis solution with dextrose as osmotic agent; dextrose creates osmotic gradient across peritoneal membrane to remove excess fluid and uremic toxins.
Intraperitoneal administration: 2 liters of 2.5% dextrose solution per exchange, typically 4 exchanges daily (8 liters total). Adjust volume and frequency based on patient's dry weight, residual renal function, and peritoneal membrane transport characteristics.
Intraperitoneal administration via automated peritoneal dialysis (APD) or continuous ambulatory peritoneal dialysis (CAPD); typical adult dose is 2-3 liters per exchange, 4-5 exchanges per day (CAPD) or 8-12 liters total volume per night (APD).
None Documented
None Documented
Dextrose: ~1-2 hours for plasma glucose levels; lactate: ~30-60 minutes for conversion to bicarbonate.
Not applicable: Dextrose absorbed from peritoneal dialysate has a half-life similar to IV glucose (approx. 1-2 hours), but as a dialysis solution, the concept of terminal elimination half-life is not defined for the non-absorbed components. Clinical context: continuous intraperitoneal administration.
Peritoneal dialysis fluid components: dextrose is metabolized to CO2 and water; lactate is converted to bicarbonate in liver; electrolytes are variably reabsorbed. ~70% of administered dextrose is absorbed; elimination primarily via metabolic pathways.
Peritoneal dialysis fluid: DIALYTE components (electrolytes, dextrose) are not systemically absorbed in clinically significant amounts; dextrose is partially absorbed across the peritoneum and metabolized. Renal and biliary excretion are not relevant as this is a topical intraperitoneal solution. Elimination of absorbed dextrose follows glucose metabolism (oxidation, storage).
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution